Boost your RNA vaccine development with reliable sample quality control

Опубликовано: 02 Апрель 2026
на канале: Agilent Technologies
231
2

The success of in vitro transcribed (IVT) RNA vaccines have helped bolster public acceptance of nucleic acid-based vaccine technologies. In this new white paper, read about the foundational research behind these life-saving vaccines and how reliable sample quality control helped the research community achieve its vaccine development goals.

Get your copy at: https://bit.ly/3zaM3Wv